Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Sclerotherapy Market, by Agent
1.4.2 North America Sclerotherapy Market, by Type
1.4.3 North America Sclerotherapy Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. North America Sclerotherapy Market by Agent
3.1 North America Detergents Market by Country
3.2 North America Osmotic Agents Market by Country
3.3 North America Chemical Irritants Market by Country
Chapter 4. North America Sclerotherapy Market by Type
4.1 North America Liquid Sclerotherapy Market by Country
4.2 North America Ultrasound Sclerotherapy Market by Country
4.3 North America Other Type Market by Country
Chapter 5. North America Sclerotherapy Market by Country
5.1 US Sclerotherapy Market
5.1.1 US Sclerotherapy Market by Agent
5.1.2 US Sclerotherapy Market by Type
5.2 Canada Sclerotherapy Market
5.2.1 Canada Sclerotherapy Market by Agent
5.2.2 Canada Sclerotherapy Market by Type
5.3 Mexico Sclerotherapy Market
5.3.1 Mexico Sclerotherapy Market by Agent
5.3.2 Mexico Sclerotherapy Market by Type
5.4 Rest of North America Sclerotherapy Market
5.4.1 Rest of North America Sclerotherapy Market by Agent
5.4.2 Rest of North America Sclerotherapy Market by Type
Chapter 6. Company Profiles
6.1 Boston Scientific Corporation
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental and Regional Analysis
6.1.4 Research & Development Expense
6.2 Perrigo Company PLC (Omega Pharmaceuticals)
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Segmental and Regional Analysis
6.2.4 Research & Development Expense
6.3 Cook Medical, Inc. (Cook Group)
6.3.1 Company Overview
6.4 Chemische Fabrik Kreussler & Co. GmbH
6.4.1 Company Overview
6.5 LGM Pharma, LLC
6.5.1 Company Overview
6.6 Troikaa Pharmaceuticals Limited
6.6.1 Company Overview
6.7 Tianyu Chang’an Group
6.7.1 Company Overview
6.8 Endo-Flex GmbH (Meditek Systems)
6.8.1 Company Overview
6.9 Merz Pharma GmbH & Co. KGaA
6.9.1 Company Overview
6.9.2 Recent strategies and developments:
6.9.2.1 Partnerships, Collaborations, and Agreements:
6.10. MTW-Endoskopie W. Haag KG
6.10.1 Company Overview
Unique Offerings 
